Denmark· DK-28106503620
Dabigatran etexilate "Sandoz"
A dabigatran etexilate product containing dabigatranetexilatmesilat, registered in Denmark by Sandoz A/S. The same ATC class is registered in 16 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Dabigatran etexilate is registered in 16 of 19 countries.
Countries holding a registration under ATC B01AE07 (dabigatran etexilate), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 10 of them publish a price we can compare per daily dose
Dabigatran etexilate · ATC B01AE07
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dabigatran etexilate costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dabigatran etexilate · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.16
- IT Italy$2.17
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Dabigatranetexilatmesilat
- Manufacturer
- Sandoz A/S
- Country
- Denmark (DK)
- ATC code
- B01AE07
- ATC class
- Dabigatran etexilate
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106503620
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
47 interactions on record for dabigatran etexilate.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dabigatran etexilate · interactions on record
47 records
47 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under B01AE07
Dabigatran etexilate, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/39c697b2-da0a-48bf-beba-2bb7852865cf GET /v1/drugs/39c697b2-da0a-48bf-beba-2bb7852865cf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "kapsler, hårde",
"source": "dkma",
"strength": "150 mg",
"auth_role": "CMS",
"dk_drugid": "28106503620",
"substance": "Dabigatranetexilatmesilat",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": true,
"registration_date_serial": "45212"
}See everything about dabigatran etexilate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.